BioRad Laboratories, headquartered in Hercules, California, develops specialty chemicals and offers products for biochemical, pharmaceutical, and life science research, employing 8,030 people. It operates in Life Science and Clinical Diagnostics segments, serving various laboratory markets.
BioRad Laboratories (BIO) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, BioRad Laboratories's actual EPS was $2.01, beating the estimate of $1.17 per share, resulting in a 72.06% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
